Summary & Overview
HCPCS Level II Q9964: High Osmolar Contrast Material, >=400 mg/ml
HCPCS Level II code Q9964 designates high osmolar iodinated contrast material with an iodine concentration of 400 mg/ml or greater, billed per milliliter. This code matters nationally because contrast agents are integral to a wide range of diagnostic and interventional imaging procedures; accurate coding affects clinical documentation, inventory tracking, and payer reimbursement workflows across hospitals and imaging centers. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical use and billing context for Q9964, plus what to expect from benchmarks and policy coverage considerations at a national level. The publication outlines typical sites of service and clinical scenarios where high-iodine concentration contrast is used, summarizes common modifiers and billing practices when available, and highlights areas where payers often establish coverage rules or prior authorization requirements. If specific payer policies or local coverage determinations are not provided, the reader will see noted where data is unavailable. The brief also points to related coding considerations for radiology supply management and procedure-level billing.
Billing Code Overview
HCPCS Level II code Q9964 represents high osmolar contrast material with an iodine concentration of 400 mg/ml or greater, billed per milliliter. This product is used as an intravascular contrast agent to enhance imaging quality during radiologic procedures that require high iodine concentration for vascular or soft-tissue visualization.
Service type: Contrast agent for diagnostic and interventional radiology
Typical site of service: Hospital outpatient radiology suites, inpatient radiology departments, and interventional radiology settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient presenting for an iodinated contrast–enhanced imaging study receives high osmolar contrast material (Q9964, high osmolar contrast material, ≥400 mg/mL iodine concentration, per mL) when the clinical team determines a high-iodine concentration agent is required or when formulary/availability necessitates its use. Typical settings include the radiology department, the CT suite, the angiography/interventional radiology (IR) suite, or the emergency department when rapid vascular opacification is needed for diagnostic CT angiography, peripheral angiography, or certain fluoroscopic angiographic studies. The typical patient is an adult requiring high-contrast density for visualization of vascular structures or lesions — for example, an adult with suspected pulmonary embolism undergoing CT pulmonary angiography, a patient scheduled for peripheral arterial angiography for critical limb ischemia, or a patient in the emergency department needing rapid vascular assessment.
Workflow: The ordering clinician documents the indication and relevant ICD-10 diagnosis on the imaging order. A registered nurse or radiology technologist screens the patient for contrast allergies, renal function (serum creatinine/eGFR), and medication interactions. Informed consent for contrast administration is obtained when indicated. The pharmacy or imaging supply system dispenses Q9964 and the radiology team logs the amount used in milliliters. The administering provider documents the contrast agent, volume, lot number, and any immediate adverse reactions. Post-procedure monitoring occurs per institutional protocol, particularly for patients with renal impairment or prior allergic reactions.
Coding Specifications
| Modifier | Description |
|---|